Q4 2025 Baxter International Inc Earnings Call Transcript
Key Points
- Baxter International Inc (BAX) reported a global sales increase of 8% on a reported basis and 3% on an operational basis for the fourth quarter of 2025.
- The Advanced Surgery business showed strong performance with an 11% growth, contributing positively across the portfolio and globally.
- The Healthcare Systems & Technologies segment maintained consistent performance, supported by the launch of the Connex 360 monitor.
- Baxter International Inc (BAX) achieved a free cash flow generation exceeding $450 million in the fourth quarter, indicating strong cash management.
- The company is focusing on innovation, with plans to continue investing in R&D at or above historical levels to drive future growth.
- Adjusted earnings per share fell short of expectations, with margins pressured by an unfavorable sales mix and nonrecurring items.
- The company is facing challenges with its Novum IQ large volume pump, leading to shipment and installation holds, impacting sales.
- Pharmaceuticals segment experienced a decline in injectables and anesthesia sales due to market demand softness and supply challenges.
- Gross margins decreased by 900 basis points compared to the prior year, affected by unfavorable product mix and higher manufacturing costs.
- The company anticipates a challenging first quarter of 2026, with expected headwinds from higher inventory costs and continued pressure in the Pharmaceuticals segment.
Good morning, ladies and gentlemen, and welcome to the Baxter International's fourth quarter 2025 earnings conference call. (Operator Instructions) As a reminder, this call is being recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter's permission. If you have any objections, please disconnect at this time,
I would now like to turn the call over to Mr. Kevin Moran, Vice President, Investor Relations at Baxter International. Mr. Moran, you may begin.
Good morning, and welcome. Today, we will discuss Baxter's fourth quarter results along with our financial outlook for the full year 2026. This morning, a press release was issued with our preliminary earnings results and updated outlook. The press release and investor presentation are available on the Investors section of the Baxter website.
Joining me today are Andrew Hider, President and Chief Executive Officer; and Joel Grade, Executive Vice President and Chief Financial Officer.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
